APGEApogee Therapeutics IncUptrendEarnings in 13 days

TodayUptrendcalm stock

Nasdaq GMBiotechnologyMarket cap $10.22BReports Nov 9, 2026

Apogee Therapeutics Inc

Sector
Healthcare
Industry
Biotechnology
Market cap
$10.22B
Employees
261
Exchange
Nasdaq GM
Country
United States
135.07−0.01% todayClose of Sep 2, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Sep 2, 2026Unlock all 8$9.90one-time

Technical readingsFree

Trend state Uptrend, stage 2 of 4, no damage flags raised (as of Oct 26, 2026)

Automated read

Price is trading above its key moving averages, but momentum readings are in extended territory: the mid-term picture reads as a stretched uptrend. RSI is currently 79.

Readings, end-of-day Sep 2, 2026
RSI (14)Overbought zone78.68, flagged reading
MACD / signalBelow signal line1.13 / 1.52, caution reading
SMA 50Price above134.13, favorable reading
SMA 200Price above91.97, favorable reading
EMA 20Price above134.49, favorable reading
ADX (14)Trending65.53
Show all 12 readings
+DI / −DI+DI leading44.60 / 8.49, favorable reading
ATR (14)0.1% of price — typical daily swing0.11
Stochastic %KOverbought zone96.87, flagged reading
Bollinger bands (20)Inside bands134.36 – 135.17
ROC (10)Positive over 10 sessions0.27, favorable reading
Trend / momentum impulseTrend and momentum agreeBoth rising, favorable impulse reading
Full analysis

What unlocking APGE reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when APGE's analysis runs, rather than checked against its stored data now.

Every section above, argued on APGE's own numbers, on one page.

See what APGE costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full APGE analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get APGE + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does Apogee Therapeutics Inc report earnings?

Apogee Therapeutics Inc (APGE) is scheduled to report earnings on Nov 9, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock APGE